Nautilus Biotechnology (NAUT) Selling, General & Administrative (2020 - 2026)
Nautilus Biotechnology (NAUT) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.13 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 216.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 593.21 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 347.92 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 247.47 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 161.89 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -196.26 Mn |
| 10 | Nautilus Biotechnology | 114.43 Mn | 114.43 Mn | 175,000.00 | 6.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.33 Mn |
| Mar 31, 2026 | 6.42 Mn |
| Dec 31, 2025 | 5.85 Mn |
| Sep 30, 2025 | 5.87 Mn |
| Jun 30, 2025 | 6.70 Mn |
| Mar 31, 2025 | 7.31 Mn |
| Dec 31, 2024 | 7.16 Mn |
| Sep 30, 2024 | 6.81 Mn |
| Jun 30, 2024 | 8.35 Mn |
| Mar 31, 2024 | 8.68 Mn |
| Dec 31, 2023 | 7.54 Mn |
| Sep 30, 2023 | 7.08 Mn |
| Jun 30, 2023 | 7.10 Mn |
| Mar 31, 2023 | 7.18 Mn |
| Dec 31, 2022 | 6.72 Mn |
| Sep 30, 2022 | 6.25 Mn |
| Jun 30, 2022 | 6.62 Mn |
| Mar 31, 2022 | 6.36 Mn |
| Dec 31, 2021 | 6.92 Mn |
| Sep 30, 2021 | 6.32 Mn |